Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Ca

Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.

Related Keywords

Canada , United States , Alan Ezekowitz , Matthew Biegler , Judah Frommer , Alex Sapir , Esther Rajavelu , Madhu Kumar , Iain Fraser , Chris Calabrese , Edward Tenthoff , Robertj Gould , Joseph Schwartz , Piper Sandler , Robert Gould , Pfizer , Credit Suisse , Glaxosmithkline , Goldman Sachs , Fulcrum Therapeutics Inc , Nasdaq , Exchange Commission , Fulcrum Therapeutics , Call Transcript May , Fulcrum Therapeutics First Quarter , Business Update Conference , Investor Section , Private Securities Litigation Reform Act , Interim Chief Executive Officer , Interim Chief Medical Officer , Facioscapulohumeral Muscular , Chief Executive Officer , Executive Vice President , United Therapeutics , Losmapimod Phase , Patient Global Impression , Chief Financial Officer , Fulcrum Board , Senior Clinical Advisor ,